ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) |
Grant Type |
Year | State |
|---|---|---|---|---|
| Investigation of Oncogenic Long Non-coding RNAs in Ewing sarcoma | Lucile Packard Children’s Hospital at Stanford University School of Medicine / Siu Ping Ngok, PhD | Young Investigator Grants | 2014 | California |
| SETD2 Mutations in Prognosis and Chemotherapy Resistance in Relapsed Acute Lymphoblastic Leukemia | Dana-Farber Cancer Institute / Brenton Mar, MD, PhD | Young Investigator Grants | 2014 | Massachusetts |
| Molecular Mechanism and Development of Therapeutic Strategies Targeting MYCN-induced Calcium Signaling in Advanced Neuroblastoma | University of Hawaii at Hilo / Ingo Koomoa-Lange, PhD | Young Investigator Grants | 2014 | Hawaii |
| Niche for in Vitro Generation of Hematopoietic Stem Cells from Pluripotent Stem Cells | Fred Hutchinson Cancer Research Center / Brandon Hadland, MD, PhD | Young Investigator Grants | 2014 | Washington |
| Targeting the Epigenome of Diffuse Intrinsic Pontine Glioma | The Johns Hopkins University School of Medicine / Sama Ahsan, MD | Young Investigator Grants | 2014 | Maryland |
| Targeting MYC/MYCN-driven Transcriptional Amplification in Pediatric Cancer | Dana-Farber Cancer Institute / Rani George, M.D., Ph.D. | Innovation Grants | 2014 | Massachusetts |
| Mechanisms and Targeted Inhibition of NT5C2 Mutations in Relapsed ALL | Columbia University / Adolfo A. Ferrando, M.D., Ph.D. | Innovation Grants | 2014 | New York |
| Modeling Juvenile Myelomonocytic Leukemia with Patient-Derived Induced Pluripotent Stem Cells | Children’s Hospital of Philadelphia / Mitchell Weiss, M.D., Ph.D. | Innovation Grants | 2014 | Pennsylvania |
| Therapies for SHH-subtype Medulloblastoma | Dana-Farber Cancer Institute / Rosalind Segal, M.D., Ph.D. | Innovation Grants | 2014 | Massachusetts |
| Correction of Hematopoietic Defects in Down Syndrome by Chromosome 21 Silencing | University of Massachusetts Medical School / Peter Newburger, M.D. | Innovation Grants | 2014 | Massachusetts |